These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia. Vinatzer U, Mannhalter C, Mitterbauer M, Gruener H, Greinix H, Schmidt HH, Fonatsch C, Wieser R. Genes Chromosomes Cancer; 2003 Jan; 36(1):80-9. PubMed ID: 12461752 [Abstract] [Full Text] [Related]
8. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption. Meyer S, Fergusson WD, Whetton AD, Moreira-Leite F, Pepper SD, Miller C, Saunders EK, White DJ, Will AM, Eden T, Ikeda H, Ullmann R, Tuerkmen S, Gerlach A, Klopocki E, Tönnies H. Genes Chromosomes Cancer; 2007 Apr; 46(4):359-72. PubMed ID: 17243162 [Abstract] [Full Text] [Related]
9. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements. Sitailo S, Sood R, Barton K, Nucifora G. Leukemia; 1999 Nov; 13(11):1639-45. PubMed ID: 10557037 [Abstract] [Full Text] [Related]
17. An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies. Bobadilla D, Enriquez EL, Alvarez G, Gaytan P, Smith D, Slovak ML. Br J Haematol; 2007 Mar; 136(6):806-13. PubMed ID: 17341266 [Abstract] [Full Text] [Related]
18. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases. Haferlach C, Bacher U, Grossmann V, Schindela S, Zenger M, Kohlmann A, Kern W, Haferlach T, Schnittger S. Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804 [Abstract] [Full Text] [Related]
19. SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus. Imoto I, Pimkhaokham A, Fukuda Y, Yang ZQ, Shimada Y, Nomura N, Hirai H, Imamura M, Inazawa J. Biochem Biophys Res Commun; 2001 Aug 24; 286(3):559-65. PubMed ID: 11511096 [Abstract] [Full Text] [Related]
20. Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration. Haas K, Kundi M, Sperr WR, Esterbauer H, Ludwig WD, Ratei R, Koller E, Gruener H, Sauerland C, Fonatsch C, Valent P, Wieser R. Genes Chromosomes Cancer; 2008 Apr 24; 47(4):288-98. PubMed ID: 18181178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]